Ikena Oncology, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol: IKNA on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 50 Northern Ave., Boston, MA

There are no Buy or Sell transactions made by insiders since 3/2/2024

Ikena Oncology, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Atlas Venture Fund XI, L.P.	10%+ Owner	$11.4M			Mar 30, 2021
David P. Bonita	Director	$489K			Jun 7, 2024
Orbimed Advisors Llc	Director	$489K			Aug 4, 2023
Maria Koehler	Director				Jun 7, 2024
Sergio Santillana	Chief Medical Officer				Jan 3, 2023
Jotin Marango	CFO & Head of Corp. Dev.				Feb 1, 2024
Jeffrey Ecsedy	Chief Development Officer				Feb 1, 2024
Mark Manfredi	President & CEO, Director				Feb 1, 2024
Otello Stampacchia	Director				Jun 7, 2024
Iain D. Dukes	Director				Jun 7, 2024
Owen Hughes	Director				Jun 7, 2024
Richard Wooster	Director				Jun 7, 2024
Francisco Oliveira	Principal Accounting Officer				Feb 18, 2022
Xiaoyan Michelle Zhang	Chief Scientific Officer				Jan 3, 2023
Caroline Germa	Chief Medical Officer				Mar 1, 2024
Maude Tessier	Chief Business Officer				Feb 2, 2022
Jean Francois Formela	Director				Jun 7, 2024
Ronald C. Renaud JR	Director				Jun 9, 2022

Showing 1 to 18 of 18 entries

Recent Insider Transactions by Companies or Individuals for Ikena Oncology, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.